Stocks and InvestingStocks and Investing
Fri, February 19, 2021
Thu, February 18, 2021
Wed, February 17, 2021
Tue, February 16, 2021

Hartaj Singh Maintained (UTHR) at Buy with Increased Target to $275 on, Feb 16th, 2021


Published on 2024-10-27 15:38:33 - WOPRAI, Hartaj Singh
  Print publication without navigation


Hartaj Singh of Oppenheimer, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $200 to $275 on, Feb 16th, 2021.

Hartaj has made no other calls on UTHR in the last 4 months.



There is 1 other peer that has a rating on UTHR. Out of the 1 peers that are also analyzing UTHR, 0 agree with Hartaj's Rating of Hold.



This is the rating of the analyst that currently disagrees with Hartaj


  • Andrew Fein of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Increased Target to $195 on, Monday, February 1st, 2021